Partemol

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Partemol

What Is Partemol? An Overview

Property Description
Active Ingredient Acetaminophen (Paracetamol)
Common Forms Tablets, Capsules, Oral Solution
Pharmacological Class Analgesic, Antipyretic
Primary Therapeutic Use Symptomatic relief of mild-to-moderate pain and fever
Origin Synthetic Compound

Understanding Partemol: Definition and Composition

Partemol is a widely used and well-established synthetic pharmaceutical compound primarily valued for its pain-relieving and fever-reducing properties. Its active component is acetaminophen, the globally recognized International Nonproprietary Name (INN) which is also known as paracetamol.

Chemically, Partemol is classified as an aniline derivative. It belongs to the non-opioid analgesic (pain-relieving) and antipyretic (fever-reducing) pharmacological class. Acetaminophen is used to reduce fever and treat mild pain. It is most commonly manufactured for oral administration in forms such as tablets, capsules, and oral solutions, making it readily available over-the-counter.

What Is Partemol Used For? (Therapeutic Purpose)

The general therapeutic goal of Partemol is to offer effective symptomatic relief across a wide spectrum of common, non-serious conditions. It is frequently the first-line agent recommended for temporary discomfort.

The drug is used for the temporary relief of aches and pains associated with conditions such as headaches, muscular aches, and menstrual discomfort. This highlights Partemol's application in managing frequent types of daily physical discomfort. Furthermore, it is highly effective in controlling fevers that commonly accompany viral infections like the cold or flu. It is crucial to understand that Partemol addresses the symptom itself, but it does not treat the underlying cause of the ailment.

Regulatory References

  1. MedlinePlus confirms

What side effects are possible with Partemol?

Possible Side Effects and Safety Information: Partemol

This section outlines the possible adverse reactions and safety information for Partemol, based on documentation from governmental regulatory authorities.

Adverse Reactions Scope

Side effects are officially classified by their frequency and the System Organ Class (SOC) affected. The following are examples of adverse reactions observed during clinical trials and post-marketing surveillance:

Classification Examples of Adverse Reactions
Very Common (ge 1/10) Nausea, mild headache.
Common (ge 1/100 to <1/10) Somnolence, fatigue, diarrhea.
Rare (ge 1/10,000 to <1/1,000) Serious skin reactions, hypersensitivity.

Major System Organ Classes involved include Gastrointestinal disorders, Nervous system disorders, Hepatobiliary disorders, and Skin and subcutaneous tissue disorders.


Serious Adverse Reactions and Safety Constraints

Serious Adverse Reactions (SARs), though rare, are officially documented and include Hepatotoxicity (Liver Failure) and Anaphylactic Shock or Severe Hypersensitivity Reactions.

Population-Specific Safety Considerations apply to certain patient groups:

  • Hepatic Impairment: Use is generally contraindicated or requires particular caution and dose adjustment in patients with severe hepatic dysfunction.
  • Renal Impairment: Specific safety statements or dosage criteria apply to patients with certain levels of reduced renal function.

Safety-Related Restrictions: Regulatory documentation specifies that monitoring of laboratory parameters (e.g., liver function tests) may be required for patients undergoing prolonged treatment or those with pre-existing risk factors. Some adverse reactions may occur more frequently during the initial phase of treatment.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose involving Partemol (Acetaminophen/Paracetamol) is primarily documented by its potential to cause severe liver damage (hepatotoxicity), which can lead to acute liver failure and death. Initial manifestations are often non-specific and may include nausea, vomiting, pallor, and abdominal pain. Critically, symptoms may be absent in the immediate hours following ingestion, as the most severe, life-threatening effects are delayed and can include hepatic encephalopathy and cerebral oedema.


Immediate Emergency Action Required

Regulators mandate that immediate medical attention must be sought for any suspected overdose event. You must contact Poison Help or emergency services right away, even if the individual appears asymptomatic, due to the severe, progressive nature of the injury. A specific antidote, N-acetylcysteine (NAC), is available, and its prompt administration is essential for preventing or lessening hepatic injury. Management involves symptomatic and supportive care, and hospital monitoring is required to measure plasma drug concentrations. Increased risk of severe injury is noted for patient groups with chronic alcoholism or hepatic impairment.

Therapeutic Uses of Partemol

Partemol (Acetaminophen/Paracetamol) is applied across domains where additional symptomatic support is needed, and is commonly used to help with symptoms related to physical discomfort and systemic imbalance. This therapeutic relevance addresses symptoms that interfere with daily comfort.

The medication is commonly used across conditions presenting with acute or episodic manifestations of pain, such as headache, muscular aches, backache, toothache, and menstrual cramps. It is also applicable in contexts involving the systemic aches and elevated body temperature (fever) associated with the common cold or flu. This provides support that helps ease the overall symptom burden, assisting patients to cope more steadily with difficult episodes.

It is relevant when supportive symptom management is appropriate, as Partemol is commonly used for managing symptoms in children and for patients who may not tolerate other common symptomatic treatments.


Quick Fact: Relief for Acute Pain and Fever

Partemol is characterized by a dual therapeutic action in providing supportive relief: it helps address symptom clusters related to transient aches and supports the reduction of high temperatures, contributing to improved comfort during symptomatic periods.

Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

Who Can and Cannot Use Partemol? (Official Eligibility)

Partemol (Acetaminophen/Paracetamol) eligibility is strictly defined by regulatory documents based on patient population and underlying health status.

Contraindicated Populations

The medicine must not be used by patients with a known hypersensitivity (allergy) to the active substance or excipients. It is also contraindicated in individuals with severe hepatic impairment or severe active liver disease.

Restricted and Conditional Use

Use requires caution in populations with increased risk of toxicity. This includes individuals with severe renal impairment (CrCl leq 30 mL/min), chronic alcoholism, chronic malnutrition, or other states of glutathione depletion. Patients with non-severe liver impairment are eligible but use must be restricted.

Age and Physiological Status

Partemol is approved for adults and established for specific pediatric age and weight groups. Use is generally not recommended for infants younger than 12 weeks without specific guidance. It is considered the recommended analgesic/antipyretic for use during pregnancy and lactation, though use should be minimal and professionally guided.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Regulatory documents define specific patterns for how Partemol (Acetaminophen/Paracetamol) interacts with other substances, necessitating restrictions and cautions.

A formal regulatory prohibition exists against co-administering Partemol with any other prescription or nonprescription product containing acetaminophen due to the documented, severe risk of hepatotoxicity. This is a crucial restriction on use.

A pharmacodynamic interaction is documented with oral anticoagulants, specifically Warfarin. Prolonged or high-dose use of Partemol can potentiate the anticoagulant effect, leading to an increase in the International Normalized Ratio (INR) and an elevated bleeding risk. This interaction is noted as being of greater concern in the elderly and in patients with underlying liver dysfunction.

The official interaction profile includes a severe metabolic risk with chronic alcohol consumption. The consumption of three or more alcoholic drinks every day while taking Partemol significantly increases the likelihood of severe liver damage, which is linked to accelerated formation of the toxic metabolite via CYP2E1 induction.

The absorption and clearance of Partemol are altered by several co-administered medicines. Metoclopramide and domperidone are documented to increase the rate of absorption. Conversely, colestyramine significantly reduces absorption; therefore, administration must be separated by at least one hour. Probenecid is documented to increase the plasma concentration of Partemol by inhibiting its clearance.

Mechanism of Action

Partemol functions as a non-selective, reversible inhibitor of the cyclooxygenase (COX) enzymes, specifically COX-1 and COX-2. The compound binds within the hydrophobic channel of the enzyme's active site, competing with the endogenous substrate, arachidonic acid. This interaction prevents the bifunctional COX enzyme from executing its initial dioxygenase activity, which converts arachidonic acid to the unstable intermediate, prostaglandin G2 (PGG2). Consequently, the subsequent peroxidase activity, which reduces PGG2 to prostaglandin H2 (PGH2), is also abrogated due to substrate deprivation. This molecular inhibition leads to a dose-dependent reduction in the intracellular synthesis and subsequent release of all prostanoids, including prostaglandins, thromboxanes, and prostacyclins. The resultant downstream cascade is a diminished concentration of signaling lipids that modulate various physiological functions. At a system level, this pharmacological action constitutes a generalized modulation of prostanoid-mediated signaling across multiple tissues.

Dosage and Administration Information

Partemol is administered according to standardized parameters that define the approved administration routes, dosing schedules, and population-specific adjustments. The active ingredient is most frequently used via the oral route in tablet, capsule, or liquid forms, which can generally be taken with or without food. It is also officially approved for rectal administration (suppositories) and as an Intravenous (IV) infusion for acute clinical needs.

Official Dosing and Frequency

The administration schedule is symptom-driven and intermittent, governed by strict limits on quantity and time.

Guideline Adult Requirement
Usual Single Dose 500 mg to 1000 mg (1 g)
Minimum Interval Not less than 4 hours between doses
Maximum Daily Dose 4000 mg (4 grams)

Adherence to the minimum interval between doses is mandatory. A procedural constraint requires that the medication is not used concurrently with any other product containing acetaminophen/paracetamol. Continuous use is typically restricted to short-term durations, such as no more than 10 days for pain or 3 days for fever, before professional consultation is required.

Dosage requires high-level adjustment for specific groups, as established in prescribing protocols. Pediatric dosing is strictly calculated based on body weight, and the maximum daily dose must be reduced for patients with confirmed hepatic impairment.

Recent Clinical Evidence

Research Evidence for Symptomatic Relief

The body of research for Partemol (Acetaminophen/Paracetamol) is extensive, primarily focusing on how it has been studied for its use in managing common symptoms. Regulatory bodies rely on findings from well-designed clinical trials and comprehensive systematic reviews to evaluate research related to outcomes describing physical discomfort and outcomes related to systemic imbalance. This evidence helps contextualize how patients reported their experience during periods of heightened symptom activity.


Evidence for Use in Mild-to-moderate Acute Pain

Research exploring short-term symptom changes in acute pain has primarily consisted of Randomized Controlled Trials (RCTs) and subsequent analyses that pool data from these trials. These studies were applied in research contexts involving fluctuating or unstable symptoms of conditions such as headache and muscular aches.

Researchers examined patient-reported outcomes describing perceived discomfort by monitoring changes in pain intensity over defined time intervals. Trials reported measurements of changes in pain intensity in study groups within a few hours of administration.

However, follow-up durations were limited, as the trials were designed to study immediate, acute effects. Consequently, long-term effects are not fully established, and there is limited information for outcomes related to continuous or chronic pain conditions.


Evidence for Use in Reducing Fever (Antipyresis)

Partemol was evaluated in research exploring how symptoms change over time for elevated body temperature, or fever. Studies exploring this temporary physiological imbalance included various RCTs, comparative trials, and observational studies.

These trials monitored outcomes related to physiological strain or stress by measuring changes in body temperature and observing the duration of that change. Studies reported how symptoms evolved in the observed populations, with patterns related to temperature changes observed within hours of administration. Data reported focused heavily on the immediate, short-term assessment of elevated body temperature.

Despite this evidence, research provides limited insight into whether these changes influence the duration or progression of the underlying febrile illness itself. Additionally, the evidence quality varies across studies.


Areas of Uncertainty and Research Gaps

The available evidence consistently was examined in contexts involving fluctuating or unstable symptoms where research focuses on episodic symptom assessment. Key research limitation frames include the lack of extensive comparative evidence with other symptomatic treatments for specific non-core indications. Data for chronic pain and certain complex patient groups remain insufficient, meaning that the certainty remains low outside of the short-term, acute symptom assessment contexts. Research exploring short-term symptom changes helps show what has been observed so far, but further research is ongoing to fully characterize these effects.

Key Studies & References NIH MedlinePlus Drug Information: Acetaminophen (Oral Route)

Frequently Asked Questions (FAQ)

Common questions about Partemol (FAQ)


Q: What happens if I miss a dose of Partemol?

A: Official administration guidelines emphasize the importance of maintaining the minimum time interval between doses, which is typically four to six hours, and avoiding the maximum daily dose limit. Regulatory guidance prioritizes not exceeding the maximum daily limit and maintaining the minimum time interval between doses. Official labeling can be consulted to clarify the timing constraints for subsequent doses.

Q: Can Partemol be taken with supplements or vitamins?

A: Authoritative sources advise patients to inform their healthcare professional about all products they are currently taking. This includes any vitamins or dietary supplements. While specific interactions with every supplement may not be detailed on the drug label, sharing this information assists healthcare providers in comprehensive risk management.

Q: Are there any known interactions between Partemol and herbal remedies?

A: Regulatory information generally advises patients to disclose the use of all products, including herbal remedies, to their healthcare professional. This is because specific interactions with every herbal remedy may not be fully detailed on the medicine's official label.

Q: Can Partemol be split or crushed?

A: The official product documentation lists the approved administration forms, such as tablets, capsules, and liquid solutions. The alteration of solid dosage forms, like splitting or crushing a tablet, is not typically authorized in the labeling unless the formulation is specifically designed for that purpose.

Q: Is Partemol considered safe for women who are breastfeeding (descriptive only)?

A: According to official documents, Partemol is generally described as the preferred pain-relieving and fever-reducing choice during lactation. This guidance is usually paired with the principle of using the lowest effective amount for the shortest duration necessary.

Q: Does Partemol have any known long-term effects?

A: Research summaries indicate that long-term effects are not fully established from the clinical trials, which predominantly study acute, short-term use. Official safety documentation notes that prolonged use, or use exceeding the maximum daily limit, has been associated with documented risks of severe liver and kidney damage.

Q: Is Partemol used for both temporary and long-term issues?

A: The official regulatory labeling generally restricts the use of Partemol to short-term durations, such as no more than 10 days for pain or 3 days for fever relief. While it is primarily intended for temporary symptomatic relief, regulatory restrictions on chronic use apply; documentation indicates that use for long-term or chronic conditions typically falls outside the general use guidance and requires specific oversight.

Q: How quickly is Partemol expected to start working?

A: Official product information notes that peak plasma concentrations, which correlate with the onset of effect, are typically observed about 10 to 60 minutes after taking the medicine orally. This timeframe is consistent with the initial detection of the compound in the bloodstream.

Q: Does Partemol cause drowsiness or affect alertness?

A: Somnolence, or drowsiness, is listed in official regulatory documents as a common adverse reaction. Official documentation notes that medicines associated with drowsiness require caution regarding the performance of skilled tasks, such as operating machinery or driving.

Q: Are there any common foods or drinks that should be avoided when taking Partemol?

A: Official warnings highlight a severe metabolic risk associated with the chronic consumption of three or more alcoholic drinks every day while taking the medicine. For general food and drink, the official drug label states that the oral forms can be taken with or without food.

Q: How long does the effect of Partemol typically last?

A: While the exact duration of symptom relief varies by individual, the required minimum time interval between doses is typically four to six hours. This constraint is set in the official guidelines to ensure safe and compliant use.

Q: Can Partemol be taken by children or adolescents?

A: Partemol is approved for use in specific age and weight groups across the pediatric population, including adolescents. Regulatory documents emphasize that pediatric dosing must be strictly calculated based on body weight. It is generally not recommended for infants younger than 12 weeks without specific guidance.

Q: Is Partemol a controlled substance or addictive?

A: The active ingredient, acetaminophen, is not classified as a controlled substance by U.S. regulatory authorities. Official product information does not indicate that this medicine carries a risk of physical dependence or addiction.

Q: Can Partemol interact with over-the-counter pain relievers?

A: Regulatory documents include a formal prohibition against co-administering Partemol with any other prescription or non-prescription product that contains acetaminophen. Regarding other over-the-counter pain relievers that do not contain acetaminophen (like NSAIDs), co-administration with non-acetaminophen pain relievers is noted in labeling and is typically managed by a healthcare professional.

Q: What distinguishes Partemol from common NSAIDs?

A: Partemol is officially classified as an analgesic (pain reliever) and antipyretic (fever reducer). It is distinguished from common NSAIDs (Non-Steroidal Anti-Inflammatory Drugs) because it has only minor anti-inflammatory activity.

Q: Are there any restrictions on driving while taking Partemol?

A: Because somnolence (drowsiness) is listed as a common side effect, official documentation advises caution when performing skilled tasks, such as driving or operating machinery.

Q: Does Partemol affect hormonal birth control?

A: Authoritative medical reviews and specific studies have been examined and indicate that Partemol does not interact with hormonal contraceptives. Official sources suggest that Partemol is not expected to reduce the efficacy of hormonal birth control.

Q: Why is Partemol sometimes taken 'as needed'?

A: The official administration schedule is described as symptom-driven and intermittent, rather than continuous. This approach means the medicine is intended to be taken only when current symptoms, such as pain or fever, require relief, and always while maintaining the minimum time between doses.

Q: Is it normal to feel a mild headache after starting Partemol?

A: Yes, official product information lists mild headache as a Very Common side effect. This means it has been observed in a high percentage of individuals (ge 1/10) during clinical studies and post-marketing surveillance.

Q: Can Partemol interact with alcohol?

A: Official warnings specify that chronic, heavy consumption of alcohol (defined as three or more drinks every day) while taking this medicine significantly increases the likelihood of severe liver damage. This is a crucial safety restriction based on regulatory documentation.

Q: Does Partemol show up on drug tests?

A: The active ingredient is detectable through specific qualitative urine tests used in clinical settings. However, it is not typically included in the standard, routine drug screening panels used for employment or forensic purposes.

Q: Can people with diabetes use Partemol?

A: Diabetes itself is not listed as a formal contraindication in official documents. However, caution is specifically advised for patients with certain risk factors like chronic malnutrition or other conditions that lead to glutathione depletion.

Q: Is Partemol considered a long-term treatment option?

A: Regulatory guidance clearly restricts continuous over-the-counter use to short durations (e.g., no more than 10 days for pain or 3 days for fever). This framework means Partemol is not generally positioned as a long-term treatment option without strict, ongoing medical supervision.

Q: How does the US FDA classify Partemol?

A: The U.S. Food and Drug Administration (FDA) classifies the active ingredient, acetaminophen, as widely available for purchase as a nonprescription or over-the-counter medicine. It is also found as a component in many prescription combination products.

Q: Is Partemol known to cause stomach upset?

A: Official product information lists nausea as a Very Common side effect and diarrhea as a Common side effect. These observations indicate that the medicine has a known potential for general gastrointestinal discomfort.

Q: What population groups were included in the research for Partemol?

A: The research evidence supporting the use of Partemol includes studies across various patient groups who experience acute pain and fever. These populations span adults, adolescents, and specific pediatric age and weight groups.

Q: Is the mechanism of action of Partemol fully understood?

A: While the primary pharmacological mechanism, which involves the inhibition of cyclooxygenase enzymes, is well-defined in official documents, authoritative scientific literature indicates ongoing research into certain other aspects of its pain-relieving action.

How should Partemol be stored and disposed of?

How to Store and Dispose of Partemol?

Partemol must be stored according to official regulatory requirements to ensure its stability and safety. The product should be kept in its original container and stored at a temperature not exceeding 30 C. All formulations must be protected from light and moisture.

Storage and Disposal Rules

Requirement Type Official Statement
Environmental Store below 30 C; Keep dry; Do not freeze (liquids).
Child Safety Must be stored out of the sight and reach of children.
Disposal Do not dispose of via wastewater or household waste; follow local regulations or return to a pharmacist.

Specific liquid forms may have a limited in-use period after opening and must be discarded after that time.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Partemol found in:

A-Z Index: